First Time Loading...

OptiNose Inc
NASDAQ:OPTN

Watchlist Manager
OptiNose Inc Logo
OptiNose Inc
NASDAQ:OPTN
Watchlist
Price: 0.905 USD -2.19% Market Closed
Updated: Apr 26, 2024

Intrinsic Value

OptiNose, Inc. operates as a pharmaceutical company. [ Read More ]

The intrinsic value of one OPTN stock under the Base Case scenario is 2.812 USD. Compared to the current market price of 0.905 USD, OptiNose Inc is Undervalued by 68%.

Key Points:
OPTN Intrinsic Value
Base Case
2.812 USD
Undervaluation 68%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
OptiNose Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling OPTN stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
OptiNose Inc

Provide an overview of the primary business activities
of OptiNose Inc.

What unique competitive advantages
does OptiNose Inc hold over its rivals?

What risks and challenges
does OptiNose Inc face in the near future?

Has there been any significant insider trading activity
in OptiNose Inc recently?

Summarize the latest earnings call
of OptiNose Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for OptiNose Inc.

Provide P/S
for OptiNose Inc.

Provide P/E
for OptiNose Inc.

Provide P/OCF
for OptiNose Inc.

Provide P/FCFE
for OptiNose Inc.

Provide P/B
for OptiNose Inc.

Provide EV/S
for OptiNose Inc.

Provide EV/GP
for OptiNose Inc.

Provide EV/EBITDA
for OptiNose Inc.

Provide EV/EBIT
for OptiNose Inc.

Provide EV/OCF
for OptiNose Inc.

Provide EV/FCFF
for OptiNose Inc.

Provide EV/IC
for OptiNose Inc.

Show me price targets
for OptiNose Inc made by professional analysts.

What are the Revenue projections
for OptiNose Inc?

How accurate were the past Revenue estimates
for OptiNose Inc?

What are the Net Income projections
for OptiNose Inc?

How accurate were the past Net Income estimates
for OptiNose Inc?

What are the EPS projections
for OptiNose Inc?

How accurate were the past EPS estimates
for OptiNose Inc?

What are the EBIT projections
for OptiNose Inc?

How accurate were the past EBIT estimates
for OptiNose Inc?

Compare the revenue forecasts
for OptiNose Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of OptiNose Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of OptiNose Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of OptiNose Inc compared to its peers.

Compare the P/E ratios
of OptiNose Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing OptiNose Inc with its peers.

Analyze the financial leverage
of OptiNose Inc compared to its main competitors.

Show all profitability ratios
for OptiNose Inc.

Provide ROE
for OptiNose Inc.

Provide ROA
for OptiNose Inc.

Provide ROIC
for OptiNose Inc.

Provide ROCE
for OptiNose Inc.

Provide Gross Margin
for OptiNose Inc.

Provide Operating Margin
for OptiNose Inc.

Provide Net Margin
for OptiNose Inc.

Provide FCF Margin
for OptiNose Inc.

Show all solvency ratios
for OptiNose Inc.

Provide D/E Ratio
for OptiNose Inc.

Provide D/A Ratio
for OptiNose Inc.

Provide Interest Coverage Ratio
for OptiNose Inc.

Provide Altman Z-Score Ratio
for OptiNose Inc.

Provide Quick Ratio
for OptiNose Inc.

Provide Current Ratio
for OptiNose Inc.

Provide Cash Ratio
for OptiNose Inc.

What is the historical Revenue growth
over the last 5 years for OptiNose Inc?

What is the historical Net Income growth
over the last 5 years for OptiNose Inc?

What is the current Free Cash Flow
of OptiNose Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for OptiNose Inc.

Financials

Balance Sheet Decomposition
OptiNose Inc

Current Assets 105.3m
Cash & Short-Term Investments 73.7m
Receivables 19.9m
Other Current Assets 11.7m
Non-Current Assets 2.4m
PP&E 815k
Other Non-Current Assets 1.6m
Current Liabilities 176.5m
Accounts Payable 3.9m
Accrued Liabilities 42.4m
Short-Term Debt 130.2m
Non-Current Liabilities 17.8m
Other Non-Current Liabilities 17.8m
Efficiency

Earnings Waterfall
OptiNose Inc

Revenue
71m USD
Cost of Revenue
-8.6m USD
Gross Profit
62.4m USD
Operating Expenses
-85.1m USD
Operating Income
-22.7m USD
Other Expenses
-12.7m USD
Net Income
-35.5m USD

Free Cash Flow Analysis
OptiNose Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

OPTN Profitability Score
Profitability Due Diligence

OptiNose Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Positive Gross Profit
Exceptional ROE
Exceptional Revenue Growth Forecast
50/100
Profitability
Score

OptiNose Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

OPTN Solvency Score
Solvency Due Diligence

OptiNose Inc's solvency score is 29/100. The higher the solvency score, the more solvent the company is.

Low D/E
Positive Net Debt
Short-Term Solvency
Long-Term Solvency
29/100
Solvency
Score

OptiNose Inc's solvency score is 29/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

OPTN Price Targets Summary
OptiNose Inc

Wall Street analysts forecast OPTN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for OPTN is 3.825 USD with a low forecast of 3.03 USD and a high forecast of 5.25 USD.

Lowest
Price Target
3.03 USD
235% Upside
Average
Price Target
3.825 USD
323% Upside
Highest
Price Target
5.25 USD
480% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

OPTN Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

OPTN Price
OptiNose Inc

1M 1M
-39%
6M 6M
-24%
1Y 1Y
-50%
3Y 3Y
-76%
5Y 5Y
-91%
10Y 10Y
-95%
Annual Price Range
0.905
52w Low
0.8942
52w High
2
Price Metrics
Average Annual Return -30.66%
Standard Deviation of Annual Returns 25.72%
Max Drawdown -92%
Shares Statistics
Market Capitalization 101.7m USD
Shares Outstanding 112 652 000
Percentage of Shares Shorted 3.19%

OPTN Return Decomposition
Main factors of price return

What is price return decomposition?

OPTN News

Other Videos

Company Profile

OptiNose Inc Logo
OptiNose Inc

Country

United States of America

Industry

Pharmaceuticals

Market Cap

101.7m USD

Dividend Yield

0%

Description

OptiNose, Inc. operates as a pharmaceutical company. The company is headquartered in Yardley, Pennsylvania and currently employs 189 full-time employees. The company went IPO on 2017-10-13. The firm's first commercial product, XHANCE (fluticasone propionate) nasal spray, 93 micrograms (mcg), is a therapeutic utilizing the Company's Exhalation Delivery System (EDS), which delivers a topically acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps and, if approved, chronic rhinosinusitis without nasal polyps. The Onzetra Xsail is a sumatriptan nasal powder and sells in the United States, Canada and Mexico.

Contact

PENNSYLVANIA
Yardley
1020 Stony Hill Rd Ste 300
+12673643500.0
https://www.optinose.com/

IPO

2017-10-13

Employees

189

Officers

CEO & Director
Dr. Ramy A. Mahmoud M.D., M.P.H.
Chief Legal Officer & Corporate Secretary
Mr. Michael F. Marino Esq.
Vice President & Chief Accounting Officer
Mr. Anthony J. Krick
Vice President of Investor Relations & Business Operations
Mr. Jonathan Neely
Chief Human Resources Officer & VP of Human Resources
Ms. Karen E. Brophy
Chief Commercial Officer
Mr. Paul Spence

See Also

Discover More
What is the Intrinsic Value of one OPTN stock?

The intrinsic value of one OPTN stock under the Base Case scenario is 2.812 USD.

Is OPTN stock undervalued or overvalued?

Compared to the current market price of 0.905 USD, OptiNose Inc is Undervalued by 68%.